87462-64-4

Basic information

• Product Name: 8-Nonyn-1-ol, 4-methylbenzenesulfonate
• CAS NO: 87462-64-4
• Molecular Formula: C16H22O3S
• Molecular Weight: 294.415
• Mol File: 87462-64-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 8-Nonyn-1-ol, 4-methylbenzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 8-Nonyn-1-ol, 4-methylbenzenesulfonate(87462-64-4)
• EPA Substance Registry System: 8-Nonyn-1-ol, 4-methylbenzenesulfonate(87462-64-4)

Safety Data

• Hazardous Substances Data: 87462-64-4(Hazardous Substances Data)

Upstream product

• 10160-28-8 8-nonyn-1-ol 
• 98-59-9 p-toluenesulfonyl chloride 
• 31333-13-8 3-nonyn-1-ol 
• 90675-38-0 non-8-ynoic acid chloride 

Relevant articles and documents

-

-

Fused ring aziridines as a facile entry into triazole fused tricyclic and bicyclic heterocycles

The intramolecular dipolar cycloaddition of an azide with an alkyne has provided a useful entry into triazole fused tricyclic heterocycles containing both the triazole ring and the oxazolidin-2-one ring system. The requisite azido-alkynes have been prepared via a two-step sequence from fused ring aziridines. A series of 6-12 membered rings containing both the oxazolidinone and triazole rings have been prepared. These ring systems have been designed as conformationally restrained analogs of RNA-binding oxazolidinones. The Royal Society of Chemistry 2012.

Effect of Tellurium Position on the Myocardial Uptake of Radioiodinated 18-Iodotellura-17-octadecenoic Acid Analogues

The effect of tellurium (Te) position on myocardial specifity and retention of fatty acids in which radioiodide is stabilized as a trans-(E)-vinyl iodode has been evaluated in rats.Five analogues of 18-iodo-17-octadecenoic acid (ICH=CH-R-Te-R'-COOH) with Te at positions 5,7,9,11, and 13 were prepared by coupling of a trans-diiodoalkene (ICH=CH-R-I) with the requisite sodium telluride substrate (NaTe-R'-COOR''; R''=Me or Et), followed by basic hydrolysis.By varying R and R', a series of analogues with a chain length of 18 carbon atoms was prepared.T he telluride substrates were generated in situ by NaBH4 reduction of the corresponding ditellurides, and the diiodoalkenes were prepared by sodium iodide-chloramine-T treatment of the corresponding vinylboronic acids .The vinylboronic acids were prepared by treatment of the terminal acetylenes (HCC-R-I), synthesized from commercially available materials, with catecholborane.All new compounds were analyzed by TLC, NMR, MS, and elemental analyses.The 125I analogues were prepared in the same manner and evaluated in rats (four per group).Heart uptake and retention were dependent upon the Te position.The analogue with Te at position 5 showed the most pronounced (5-min values) heart uptake (3.7-4.1 dose/g), myocardial retention, and heart/blood ratios (37:1) and is a candidate for radiolabeling with 123I and further evaluation as a myocardial imaging agent.